menu toggle

March 3, 2020

Breaking Through Barriers to Access at the 21st Annual Patient Assistance & Access Programs Conference in Baltimore

*PAP 2020 Has Been Postponed*

The organizers of PAP 2020 have informed us that due to the increasing travel restrictions from developments with COVID-19 and feedback from key stakeholders, PAP 2020 – 21st Annual Patient Assistance and Access Programs  has been postponed.

We have not been told of a confirmed date or location, but they are working hard on those arrangements and will announce details as soon as possible.

We are proud to support the Annual Patient Assistance and Access Programs conference every year and we look forward to joining the conference at a later date. 

Optimizing Access for Our Partners

Join us in Baltimore and learn how we can optimize access and navigate patient assistance for your therapy.

Baltimore skyline

2020 Speaker Highlights

Corey Ford

Tuesday, March 24, 2020 | 10:15 AM ET

STATE OF THE INDUSTRY: Tracking the Intersection of Patient Access and Shifts in Healthcare Legislation

Corey Ford
Speakers: Corey Ford, MHA, Director, Reimbursement & Policy Insights at Xcenda and Melissa Muchahey, Vice President, Field Services, Client Engagement & Business Development at Xcenda


Join Xcenda's Corey Ford and Melissa Mulchahey as they speak to the current state of the industry. In this evolving healthcare landscape, Mr. Ford and Ms. Mulchahey will gauge the shifting healthcare policy landscape with a focus on patient access and healthcare legislation.

Corey Ford

Kristine Flemister, President

Wednesday, March 25, 2020 | 9:45 AM ET

Compassion Drives Innovation: Modern Approaches to Ensure Optimal Outcomes for Patients with Cancer

Kristine Flemister, President
Panelist: Kristine Flemister, PharmD, President of Xcenda 

There are more and better options to treat cancer today thanks to research and development of scientists, researchers and manufacturers. Yet, this level of innovation is costly and gaining access to new, specialty therapies is often obstructed by financial burden, confusing benefits design, delays in authorizations and complex treatment regimens.  All of these barriers play a pivotal role in preventing patients from realizing the true promise that emerging therapies can provide.

During this interactive panel discussion, leaders from Family Reach, Xcenda and Lash Group provide their collective expert insights on key strategies to break down barriers to innovative new, cancer treatments.
Kristine Flemister, President

prescription bottles

Additional Insights from Xcenda

The Impact of Step-Therapy Policies on Patients

When payers insert themselves into the clinical decision-making process, it can diminish the trust and confidence patients have in their healthcare providers. Download this complimentary paper written by Xcenda in collaboration with Madelaine A. Feldman, MD, FACR that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system.

Xcenda is proud to support PAP 2020 as a platinum sponsor.

Connect with us at the event and learn more about our perspective on the future of patient assistance and access.